SFFS
GSK icon

Stonehage Fleming Financial Services’s GSK GSK Stock Holding History

Stonehage Fleming Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-950
Closed -$51K – 159
2014
Q4 		$51K Buy
+950
New +$53.1K 0.01% 138

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stonehage Fleming Financial Services's GSK Position: Q1 2015 in Review

Stonehage Fleming Financial Services sold out of GSK (GSK) in Q1 2015, closing a stake of 950 shares — an estimated $51K sold.

Stonehage Fleming Financial Services first reported a position in GSK in Q4 2014 and held it in 1 quarter. The position peaked at $51K in Q4 2014. 740 funds tracked by Wall St. Rank hold GSK as of Q1 2015.

  • Stonehage Fleming Financial Services reported no remaining GSK position as of Q1 2015 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 950 GSK shares in Q1 2015, an estimated $51K.
  • Stonehage Fleming Financial Services first reported a position in GSK in Q4 2014 and held it in 1 quarter.
  • Stonehage Fleming Financial Services's GSK position peaked at $51K in Q4 2014.
  • 740 funds tracked by Wall St. Rank held GSK as of Q1 2015.

Based on Stonehage Fleming Financial Services's 13F filing for Q1 2015, filed 11 Oct 2019.